{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "47002c2b-116f-4cc1-8dc8-14fce5dea216",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "\n",
    "data = pd.read_excel(\"./resources/de_jong_et_al_2025_supp_mat.xlsx\", sheet_name=\"Table S5\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "0ce84dcf-ea54-401f-8e59-06bc4993687f",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['cell_status', 'annotation_coarse', 'annotation_granular',\n",
       "       'top_sig_enriched_pathways', 'sig_upreglated_top10'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "647c26e4-d1d7-418e-9eb9-ac36ea373eef",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>cell_status</th>\n",
       "      <th>annotation_coarse</th>\n",
       "      <th>annotation_granular</th>\n",
       "      <th>top_sig_enriched_pathways</th>\n",
       "      <th>sig_upreglated_top10</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Malignant</td>\n",
       "      <td>AC-gliosis-like</td>\n",
       "      <td>AC-gliosis-like 1</td>\n",
       "      <td>['HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION',...</td>\n",
       "      <td>['POSTN', 'JPH1', 'EYA4', 'RTN1', 'LAMA2', 'AC...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Malignant</td>\n",
       "      <td>AC-gliosis-like</td>\n",
       "      <td>AC-gliosis-like 2</td>\n",
       "      <td>['GOBP_WOUND_HEALING', 'HALLMARK_EPITHELIAL_ME...</td>\n",
       "      <td>['CFAP54', 'IGFBP7', 'VOPP1', 'AQP4', 'LANCL2'...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Malignant</td>\n",
       "      <td>AC-gliosis-like</td>\n",
       "      <td>AC-gliosis-like 3</td>\n",
       "      <td>['HALLMARK_TNFA_SIGNALING_VIA_NFKB', 'GOBP_MON...</td>\n",
       "      <td>['LAMA2', 'AC012405.1', 'COL8A1', 'AC007402.1'...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  cell_status annotation_coarse annotation_granular  \\\n",
       "0   Malignant   AC-gliosis-like   AC-gliosis-like 1   \n",
       "1   Malignant   AC-gliosis-like   AC-gliosis-like 2   \n",
       "2   Malignant   AC-gliosis-like   AC-gliosis-like 3   \n",
       "\n",
       "                           top_sig_enriched_pathways  \\\n",
       "0  ['HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION',...   \n",
       "1  ['GOBP_WOUND_HEALING', 'HALLMARK_EPITHELIAL_ME...   \n",
       "2  ['HALLMARK_TNFA_SIGNALING_VIA_NFKB', 'GOBP_MON...   \n",
       "\n",
       "                                sig_upreglated_top10  \n",
       "0  ['POSTN', 'JPH1', 'EYA4', 'RTN1', 'LAMA2', 'AC...  \n",
       "1  ['CFAP54', 'IGFBP7', 'VOPP1', 'AQP4', 'LANCL2'...  \n",
       "2  ['LAMA2', 'AC012405.1', 'COL8A1', 'AC007402.1'...  "
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data[0:3]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "832c331d-074f-4483-a5df-d679c4ac47e7",
   "metadata": {},
   "outputs": [],
   "source": [
    "data['plain_query'] = ''\n",
    "data['contextual_query'] = ''\n",
    "data['cell_status_sub'] = data['cell_status'].replace('TME', 'tumour microenvironment')\n",
    "data['annotation_coarse_sub'] = data['annotation_coarse'].replace('AC', 'Astrocyte', regex=True)\n",
    "out = data.to_dict('records')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "b5ec88a2-598b-4115-8214-b5166bc11e1d",
   "metadata": {},
   "outputs": [],
   "source": [
    "#gene_list = ['CFAP54', 'IGFBP7', 'VOPP1', 'AQP4', 'LANCL2', 'AC074351.1', 'DTHD1', 'AC012405.1', 'RTN1', 'MTRNR2L12']\n",
    "#annotated_type = 'astrocyte precursor'\n",
    "\n",
    "for o in out:\n",
    "\n",
    "    o['contextual_query'] = ' '.join([f\"The following is a list of genes enriched in {o['cell_status_sub']} cells from a\",\n",
    "                             \"(human) patient with glioblastoma \",\n",
    "        f\"annotated as {o['annotation_coarse_sub']}. \",\n",
    "        \"What might this list say about the state, properties and interactions of this cell type? \",\n",
    "        \"Do not limit your answers to the cancer literature, \",\n",
    "        \"include normal cell-cell interactions, development and cross-cutting metabolic states. \",\n",
    "        f\"Gene list: {o['sig_upreglated_top10']}\"])\n",
    "\n",
    "    o['plain_query'] = \"What might the following enriched gene lists say about the type, \" \\\n",
    "              f\"properties and cell-cell interactions of the cells the list was derived from { o['sig_upreglated_top10'] }\"\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "04c9335d-554c-4243-a14e-f911b6e795b6",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'cell_status': 'Malignant',\n",
       " 'annotation_coarse': 'AC-gliosis-like',\n",
       " 'annotation_granular': 'AC-gliosis-like 1',\n",
       " 'top_sig_enriched_pathways': \"['HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION', 'GOBP_AMEBOIDAL_TYPE_CELL_MIGRATION', 'GOBP_TISSUE_MIGRATION', 'GOBP_REGULATION_OF_EPITHELIAL_CELL_MIGRATION', 'GOBP_ENDOTHELIAL_CELL_MIGRATION']\",\n",
       " 'sig_upreglated_top10': \"['POSTN', 'JPH1', 'EYA4', 'RTN1', 'LAMA2', 'AC092957.1', 'TNC', 'IGFBP7', 'COL23A1', 'NAMPT']\",\n",
       " 'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['POSTN', 'JPH1', 'EYA4', 'RTN1', 'LAMA2', 'AC092957.1', 'TNC', 'IGFBP7', 'COL23A1', 'NAMPT']\",\n",
       " 'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as Astrocyte-gliosis-like.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['POSTN', 'JPH1', 'EYA4', 'RTN1', 'LAMA2', 'AC092957.1', 'TNC', 'IGFBP7', 'COL23A1', 'NAMPT']\",\n",
       " 'cell_status_sub': 'Malignant',\n",
       " 'annotation_coarse_sub': 'Astrocyte-gliosis-like'}"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "out[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "93fbb6df-7257-437f-a997-63923e19db70",
   "metadata": {},
   "outputs": [],
   "source": [
    "import requests\n",
    "import concurrent.futures\n",
    "import os\n",
    "\n",
    "# --- API Setup ---\n",
    "key = os.getenv(\"PERPLEXITY_API_KEY\")\n",
    "url = \"https://api.perplexity.ai/chat/completions\"\n",
    "headers = {\n",
    "    \"accept\": \"application/json\",\n",
    "    \"authorization\": f\"Bearer {key}\",\n",
    "    \"content-type\": \"application/json\"\n",
    "}\n",
    "\n",
    "base_payload = {\n",
    "    \"model\": \"sonar-deep-research\",\n",
    "    \"return_citations\": True,\n",
    "        \"search_domain_filter\": [\n",
    "            \"pubmed.ncbi.nlm.nih.gov\",\n",
    "            \"ncbi.nlm.nih.gov/pmc/\",\n",
    "            \"sciencedirect.com\",\n",
    "            \"nature.com\",\n",
    "            \"cell.com\",\n",
    "            \"frontiersin.org\",\n",
    "            \"journals.plos.org\",\n",
    "            \"wikipedia.org\",\n",
    "        ],\n",
    "    \"messages\": [\n",
    "        {\"role\": \"system\", \"content\": \"You are an expert biologist. Your answers must be based on primary scientific literature and major reviews from peer-reviewed sources.\"},\n",
    "        {\"role\": \"user\", \"content\": \"\"}\n",
    "    ]\n",
    "}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "a3cddf44-ffb5-425c-9d5c-94181928b233",
   "metadata": {},
   "outputs": [],
   "source": [
    "import time\n",
    "\n",
    "def query_perplexity(o):\n",
    "    local_payload = base_payload.copy()\n",
    "    \n",
    "    # Plain query\n",
    "    local_payload['messages'][1]['content'] = o['plain_query']\n",
    "    try:\n",
    "        plain_resp = requests.post(url, headers=headers, json=local_payload).json()\n",
    "    except Exception as e:\n",
    "        plain_resp = {\"error\": str(e)}\n",
    "\n",
    "    # Add a 1-second delay between the two requests\n",
    "    time.sleep(1) \n",
    "\n",
    "\n",
    "    # Contextual query\n",
    "    local_payload['messages'][1]['content'] = o['contextual_query']\n",
    "    try:\n",
    "        contextual_resp = requests.post(url, headers=headers, json=local_payload).json()\n",
    "    except Exception as e:\n",
    "        contextual_resp = {\"error\": str(e)}\n",
    "    \n",
    "    # Store in the object\n",
    "    o['plain_response'] = plain_resp\n",
    "    o['contextual_response'] = contextual_resp\n",
    "\n",
    "    return o"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "9f6d88c0-ebe3-4e94-af69-3fb939960926",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Starting API calls...\n",
      "All API calls completed.\n"
     ]
    }
   ],
   "source": [
    "# Use a ThreadPoolExecutor to run the query function on all items in the 'out' list\n",
    "# This will run multiple requests at the same time, making the process much faster.\n",
    "\n",
    "with concurrent.futures.ThreadPoolExecutor(max_workers=2) as executor:\n",
    "    # The map function applies 'query_perplexity' to each item in 'out'\n",
    "    # and returns the results in the same order.\n",
    "    print(\"Starting API calls...\")\n",
    "    results = list(executor.map(query_perplexity, out))\n",
    "    print(\"All API calls completed.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "2bd6b060-77aa-4db6-8d64-0bd7e63c0e44",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'cell_status': 'Malignant',\n",
       " 'annotation_coarse': 'AC-gliosis-like',\n",
       " 'annotation_granular': 'AC-gliosis-like 1',\n",
       " 'top_sig_enriched_pathways': \"['HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION', 'GOBP_AMEBOIDAL_TYPE_CELL_MIGRATION', 'GOBP_TISSUE_MIGRATION', 'GOBP_REGULATION_OF_EPITHELIAL_CELL_MIGRATION', 'GOBP_ENDOTHELIAL_CELL_MIGRATION']\",\n",
       " 'sig_upreglated_top10': \"['POSTN', 'JPH1', 'EYA4', 'RTN1', 'LAMA2', 'AC092957.1', 'TNC', 'IGFBP7', 'COL23A1', 'NAMPT']\",\n",
       " 'plain_query': \"What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['POSTN', 'JPH1', 'EYA4', 'RTN1', 'LAMA2', 'AC092957.1', 'TNC', 'IGFBP7', 'COL23A1', 'NAMPT']\",\n",
       " 'contextual_query': \"The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as Astrocyte-gliosis-like.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['POSTN', 'JPH1', 'EYA4', 'RTN1', 'LAMA2', 'AC092957.1', 'TNC', 'IGFBP7', 'COL23A1', 'NAMPT']\",\n",
       " 'cell_status_sub': 'Malignant',\n",
       " 'annotation_coarse_sub': 'Astrocyte-gliosis-like',\n",
       " 'plain_response': {'id': '0a8c8072-ae3f-4227-9fad-32c0ac02b890',\n",
       "  'model': 'sonar-deep-research',\n",
       "  'created': 1752581789,\n",
       "  'usage': {'prompt_tokens': 108,\n",
       "   'completion_tokens': 3682,\n",
       "   'total_tokens': 3790,\n",
       "   'citation_tokens': 11847,\n",
       "   'num_search_queries': 33,\n",
       "   'reasoning_tokens': 52957},\n",
       "  'citations': ['https://pubmed.ncbi.nlm.nih.gov/26224312/',\n",
       "   'https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2024.1420862/full',\n",
       "   'https://pubmed.ncbi.nlm.nih.gov/32083568/',\n",
       "   'https://pubmed.ncbi.nlm.nih.gov/28222512/',\n",
       "   'https://pubmed.ncbi.nlm.nih.gov/25273559/',\n",
       "   'https://pubmed.ncbi.nlm.nih.gov/39433822/',\n",
       "   'https://pubmed.ncbi.nlm.nih.gov/28733667/',\n",
       "   'https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1131051/full',\n",
       "   'https://pubmed.ncbi.nlm.nih.gov/28034876/',\n",
       "   'https://pubmed.ncbi.nlm.nih.gov/34180136/',\n",
       "   'https://pubmed.ncbi.nlm.nih.gov/23105016/',\n",
       "   'https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2020.599834/full',\n",
       "   'https://en.wikipedia.org/wiki/IGFBP7',\n",
       "   'https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1434300/full',\n",
       "   'https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.927479/full',\n",
       "   'https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2024.1421438/full',\n",
       "   'https://pubmed.ncbi.nlm.nih.gov/19393298/'],\n",
       "  'search_results': [{'title': 'CFAP54 is required for proper ciliary motility and assembly ...',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/26224312/',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'The multifaceted role of insulin-like growth factor binding ...',\n",
       "    'url': 'https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2024.1420862/full',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'The role of vesicular overexpressed in cancer pro-survival ...',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/32083568/',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'AQP4 Association with Amyloid Deposition and Astrocyte ...',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/28222512/',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'Lanthionine synthetase C-like protein 2 (LanCL2) is a ...',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/25273559/',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'A meta-analysis of bulk RNA-seq datasets identifies ...',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/39433822/',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'RTN1 and RTN3 protein are differentially associated with ...',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/28733667/',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'Identification of genes related to immune enhancement ...',\n",
       "    'url': 'https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1131051/full',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'An indel polymorphism within pre-miR3131 confers risk for ...',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/28034876/',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'Identification and characterization of N6-methyladenosine ...',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/34180136/',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'Autozygome-guided exome sequencing in retinal ...',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/23105016/',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'An Integrated Transcriptome Analysis Reveals IGFBP7 ...',\n",
       "    'url': 'https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2020.599834/full',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'IGFBP7',\n",
       "    'url': 'https://en.wikipedia.org/wiki/IGFBP7',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'IGFBP7+ subpopulation and IGFBP7 risk score in ...',\n",
       "    'url': 'https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1434300/full',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'Ependymal Cilia: Physiology and Role in Hydrocephalus',\n",
       "    'url': 'https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.927479/full',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'Insulin-like growth factor-binding protein 7 (IGFBP7)',\n",
       "    'url': 'https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2024.1421438/full',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'Aquaporin-4 maintains ependymal integrity in adult mice',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/19393298/',\n",
       "    'date': None,\n",
       "    'last_updated': None}],\n",
       "  'object': 'chat.completion',\n",
       "  'choices': [{'index': 0,\n",
       "    'finish_reason': 'stop',\n",
       "    'message': {'role': 'assistant',\n",
       "     'content': '<think>\\nWe are given a list of genes: [\\'CFAP54\\', \\'IGFBP7\\', \\'VOPP1\\', \\'AQP4\\', \\'LANCL2\\', \\'AC074351.1\\', \\'DTHD1\\', \\'AC012405.1\\', \\'RTN1\\', \\'MTRNR2L12\\'].\\n\\nWe are to analyze what this enriched gene list might say about the type, properties, and cell-cell interactions of the cells from which the list was derived.\\n\\n### Step 1: Understand the function of each gene\\n\\nWe have several genes. We will use the provided search results to understand each gene\\'s function and relevance.\\n\\n1. **CFAP54**: From search result [1], CFAP54 is required for proper ciliary motility and assembly. Mutations in CFAP54 lead to defects in the C1d projection of cilia, resulting in decreased ciliary beat frequency and perturbed cilia-driven flow. It is associated with primary ciliary dyskinesia (PCD). In [15], CFAP54 mutations cause reduced ependymal ciliary beating frequency and loss of the C1d projection. Ependymal cilia are important for cerebrospinal fluid (CSF) flow.\\n\\n2. **IGFBP7**: From [2], [12], [13], and [16], IGFBP7 is an insulin-like growth factor binding protein that is expressed in various tissues, including endothelial cells, and plays roles in angiogenesis, cell adhesion, and tumor suppression. It is also implicated in Alzheimer\\'s disease and memory function. In [2], it is present in glandular epithelial cells and stromal cells. In [12], IGFBP7 is upregulated in vasculature in response to brain injury and is associated with TGFβ signaling. In [13], it is involved in memory and Alzheimer\\'s disease. In [16], it is crucial in lumen formation during angiogenesis and has anti-inflammatory and anti-fibrotic properties.\\n\\n3. **VOPP1**: From [3], VOPP1 (Vesicular overexpressed in cancer pro-survival protein 1) is overexpressed in several cancers and promotes cell proliferation and survival by targeting the MAPK and mTOR pathways. It is associated with hepatocellular carcinoma (HCC) progression.\\n\\n4. **AQP4**: From [4], [17], AQP4 is an aquaporin water channel that is highly expressed in astrocyte endfeet and ependymal cells. It plays a role in water homeostasis in the brain and is associated with amyloid deposition in Alzheimer\\'s disease. In [17], AQP4 maintains ependymal integrity and is involved in CSF production and brain water content.\\n\\n5. **LANCL2**: From [5], LANCL2 is a positive regulator of Akt activation. It directly interacts with Akt and mTORC2, enhancing Akt phosphorylation. It promotes cell survival and inhibits apoptosis.\\n\\n6. **AC074351.1**: Not explicitly mentioned in the provided search results. This appears to be a non-coding RNA or a gene with an accession number. Without specific information, we might infer from the context of other genes.\\n\\n7. **DTHD1**: From [6], [9], [10], and [11], DTHD1 is a gene that has been associated with Alzheimer\\'s disease as a potential biomarker (downregulated in AD) and also with retinal dystrophy and hepatocellular carcinoma. In [9], DTHD1 is a target of miR-3131 in HCC. In [10], DTHD1 is identified as a potential candidate in glioblastoma. In [11], DTHD1 is a candidate disease gene for retinal dystrophy.\\n\\n8. **AC012405.1**: Not explicitly mentioned. This is another accession number, likely a non-coding RNA or uncharacterized gene.\\n\\n9. **RTN1**: From [7], RTN1 is a reticulon protein that interacts with BACE1 and modulates its secretase activity. It is differentially expressed in Alzheimer\\'s brains and is localized in dendrites. RTN1 and RTN3 have differential effects on senile plaques.\\n\\n10. **MTRNR2L12**: From [8], MTRNR2L12 is a long non-coding RNA (lncRNA) that is anti-apoptotic. It is downregulated in B cells after vaccination and is associated with cellular stress. Low expression may be associated with reduced adverse vaccine reactions.\\n\\n### Step 2: Identify common themes and cell types\\n\\n- **Cilia and Ependymal Cells**: CFAP54 is critical for ciliary function and is expressed in ependymal cells. AQP4 is also expressed in ependymal cells and maintains their integrity. Both are involved in CSF dynamics. This suggests that the cell type might have ciliated ependymal cells or be related to the ventricular system.\\n\\n- **Angiogenesis and Endothelial Cells**: IGFBP7 is expressed in endothelial cells and is involved in angiogenesis and response to injury. AQP4 is also found in astrocyte endfeet which are in close contact with endothelial cells. This suggests a vascular component.\\n\\n- **Neurodegeneration and Gliopathies**: AQP4 is associated with amyloid deposition in Alzheimer\\'s disease and astrocyte pathology. RTN1 is involved in Alzheimer\\'s disease via modulation of BACE1. IGFBP7 is implicated in Alzheimer\\'s disease and memory. DTHD1 is linked to Alzheimer\\'s as a biomarker. This points to a role in neurodegenerative conditions.\\n\\n- **Cancer and Proliferation**: VOPP1 promotes proliferation in cancer. LANCL2 promotes cell survival via Akt. IGFBP7 has both tumor suppressor and promoter roles depending on context. DTHD1 is linked to cancer (HCC). This suggests proliferative and survival properties.\\n\\n- **Non-coding RNAs**: AC074351.1 and AC012405.1 are not characterized in the provided data, but MTRNR2L12 is an anti-apoptotic lncRNA. This indicates regulatory roles at the RNA level.\\n\\n- **Stress Response and Apoptosis**: MTRNR2L12 is anti-apoptotic and associated with cellular stress. LANCL2 is anti-apoptotic via Akt. IGFBP7 can induce apoptosis in some contexts.\\n\\n### Step 3: Synthesize the cell type and properties\\n\\nGiven the genes:\\n\\n- The presence of genes associated with ependymal cells (CFAP54, AQP4) and ciliary function suggests that the cells are likely **ependymal cells** or cells with ciliary functions. Given the importance of ependymal cilia in CSF flow and the involvement of AQP4 in ependymal integrity, this is a strong candidate.\\n\\n- Additionally, the involvement in neurodegenerative pathways (AQP4, RTN1, IGFBP7, DTHD1) and angiogenesis (IGFBP7) might indicate that these cells are in an environment of brain injury or neuroinflammation, such as in the context of astrocytoma or glioblastoma (as IGFBP7 is also implicated in glioma, see [14]).\\n\\n- The expression of genes related to proliferation and survival (VOPP1, LANCL2) might suggest a proliferative state, which is characteristic of cancer cells, but in the context of the brain, this could be in glioma.\\n\\n- The presence of non-coding RNAs (MTRNR2L12, and possibly AC074351.1 and AC012405.1) indicates regulatory functions, which are common in complex cellular responses.\\n\\nTherefore, the enriched gene list likely comes from **ependymal cells or ependymal cell-related conditions, possibly in a context of injury, neurodegeneration, or neoplasia (like glioma)**.\\n\\n### Step 4: Cell-cell interactions\\n\\n- **Cilia-Driven CSF Flow**: Ependymal cells with functional cilia (requiring CFAP54) interact with the CSF and help in its flow. This affects the entire ventricular system and brain.\\n\\n- **Vascular Interactions**: IGFBP7 is expressed in endothelial cells and may mediate interactions between ependymal cells and the vasculature. AQP4 is in ependymal cells and also in astrocyte endfeet, suggesting interactions with astrocytes and blood vessels.\\n\\n- **Neurodegeneration and Glial Interactions**: In Alzheimer\\'s disease, AQP4 and IGFBP7 are associated with amyloid deposition and astrocyte pathology. RTN1 is involved in plaque formation. This suggests interactions with neurons and astrocytes.\\n\\n- **Immune and Inflammatory Responses**: IGFBP7 has anti-inflammatory properties. MTRNR2L12 is associated with stress and immune responses (vaccination context). This might indicate interactions with immune cells.\\n\\n- **Tumor Microenvironment**: In glioma (as per [14]), IGFBP7+ cells are a subpopulation that influences astrocytoma progression. This suggests interactions within the tumor microenvironment, including with other glioma cells and possibly immune cells.\\n\\n### Conclusion\\n\\nThe gene list suggests that the cells are likely **ependymal cells** or cells in the ependymal lineage, possibly in a state of activation due to injury, neurodegeneration, or neoplasia (such as glioma). The properties include:\\n\\n1. **Ciliary function and CSF dynamics** (CFAP54, AQP4)\\n2. **Angiogenesis and vascular interactions** (IGFBP7)\\n3. **Neurodegeneration and plaque formation** (AQP4, RTN1, IGFBP7, DTHD1)\\n4. **Cell survival and proliferation** (LANCL2, VOPP1, MTRNR2L12)\\n5. **Regulatory non-coding RNAs** (MTRNR2L12, AC074351.1, AC012405.1)\\n\\nCell-cell interactions involve:\\n\\n- Interactions with CSF and the ventricular system via cilia.\\n- Interactions with the vasculature and astrocytes (via AQP4 and IGFBP7).\\n- In pathological contexts (like glioma), interactions within the tumor microenvironment.\\n\\nThis analysis is based on the provided search results and the known functions of the genes.\\n</think>\\nBased on the enriched gene list (CFAP54, IGFBP7, VOPP1, AQP4, LANCL2, AC074351.1, DTHD1, AC012405.1, RTN1, MTRNR2L12) and extensive analysis of the provided research context, the cells exhibit properties characteristic of **ependymal cells and glial-vascular interface cells in neurodegenerative and oncological contexts**. Below is a comprehensive analysis of cell type, properties, and cell-cell interactions:\\n\\n---\\n\\n### **1. Ependymal Cell Identity and Ciliary Function**\\n- **CFAP54-Dependent Cilia Assembly**:  \\n  CFAP54 is essential for proper ciliary motility and structural integrity in ependymal cells[1][15]. Mutations cause loss of the C1d projection in motile cilia, reducing ciliary beat frequency and disrupting cerebrospinal fluid (CSF) flow[1]. This leads to hydrocephalus due to impaired CSF circulation[15].  \\n- **AQP4 in Ependymal Integrity**:  \\n  AQP4 maintains ependymal cell polarization and structural integrity by anchoring to basolateral membranes. AQP4 deficiency disrupts gap junctions (e.g., connexin43), reducing CSF production and increasing brain water content[17].  \\n\\n**Properties**:  \\n- **Motile Cilia Density**: ~50 cilia per cell with \"9+2\" microtubule arrays[15].  \\n- **Polarized Organization**: Basal bodies exhibit rotational polarity for coordinated ciliary beating[15].  \\n- **CSF Dynamics**: Cilia drive directional CSF flow from lateral ventricles to subarachnoid space[15].  \\n\\n---\\n\\n### **2. Neurodegenerative and Gliovascular Roles**\\n#### **A. IGFBP7 in Vasculature and Astrocyte Crosstalk**\\n- **TGFβ-Mediated Upregulation**:  \\n  IGFBP7 is upregulated in endothelial cells (ECs) upon TGFβ stimulation, particularly after brain injury or in Alzheimer\\'s disease (AD) pathology[12][16]. It localizes to vascular basement membranes and binds collagen IV, facilitating EC adhesion and angiogenesis[2][16].  \\n- **AD Biomarker**:  \\n  IGFBP7 elevation in AD impairs memory consolidation and is linked to amyloid deposition. Blocking IGFBP7 restores memory function in AD models[13].  \\n\\n#### **B. AQP4 in Amyloid Pathology**\\n- **Plaque-Associated Redistribution**:  \\n  AQP4 redistributes to astrocyte processes surrounding amyloid plaques in AD, correlating with plaque maturation stages[4]. This suggests AQP4 facilitates amyloid-β aggregation and glial activation[4][17].  \\n\\n#### **C. RTN1 in Neuronal Integrity**\\n- **Dendritic Localization**:  \\n  RTN1 marks dendrites (e.g., Purkinje cells) and modulates BACE1 activity, influencing amyloidogenesis. Unlike RTN3, it is not enriched in dystrophic neurites around plaques[7].  \\n\\n**Properties**:  \\n- **Stress-Responsive Secretome**: IGFBP7 and AQP4 respond to hypoxia/TGFβ in injury[12][16].  \\n- **Barrier Functions**: AQP4 and IGFBP7 regulate blood-brain barrier (BBB) permeability and ion/water homeostasis[4][17].  \\n\\n---\\n\\n### **3. Oncogenic and Survival Pathways**\\n#### **A. Pro-Survival Signaling**\\n- **LANCL2-Akt-mTOR Axis**:  \\n  LANCL2 directly binds Akt and mTORC2, enhancing Akt phosphorylation and inhibiting apoptosis[5]. This pathway promotes cell survival in neural and hepatic contexts[5][9].  \\n- **VOPP1 in Tumor Progression**:  \\n  VOPP1 upregulation in hepatocellular carcinoma (HCC) activates MAPK/mTOR pathways, driving proliferation and tumor growth[3].  \\n\\n#### **B. Non-Coding RNA Regulation**\\n- **MTRNR2L12 (Anti-Apoptotic lncRNA)**:  \\n  This lncRNA suppresses apoptosis and correlates with cellular stress. Downregulation reduces adverse inflammatory reactions (e.g., post-vaccination)[8].  \\n- **AC074351.1 and AC012405.1**:  \\n  These unannotated RNAs may regulate stress responses or epigenetic remodeling, similar to MTRNR2L12[8][10].  \\n\\n**Properties**:  \\n- **Therapeutic Targets**: LANCL2/VOPP1 are candidate targets for cancer therapy[3][5].  \\n- **Stress Adaptation**: MTRNR2L12 buffers against oxidative or inflammatory stress[8].  \\n\\n---\\n\\n### **4. Cell-Cell Interactions**\\n#### **A. Ependymal-Vascular Interface**\\n- **IGFBP7-Mediated Angiogenesis**:  \\n  IGFBP7 secretion by ependymal/ECs stimulates endothelial adhesion to collagen IV, promoting vascular lumen formation[16]. In injury, TGFβ from microglia/ECs upregulates IGFBP7, enhancing BBB repair[12].  \\n- **Cilia-Driven Nutrient Exchange**:  \\n  Ependymal cilia facilitate CSF-mediated nutrient/waste exchange with parenchymal vessels[15].  \\n\\n#### **B. Neuroglial Interactions in Pathology**\\n- **Amyloid Clearance Coordination**:  \\n  AQP4[4] and IGFBP7[13] on astrocytes interact with amyloid plaques, while ependymal cilia drive glymphatic CSF flow for clearance[15].  \\n- **Tumor Microenvironment**:  \\n  In glioma, IGFBP7+ subpopulations (C0) influence astrocytoma differentiation and prognosis via FAM20C/TIMP1 expression[14].  \\n\\n#### **C. Immune Modulation**\\n- **MTRNR2L12 in B Cells**:  \\n  Downregulation in B cells post-vaccination correlates with reduced adverse reactions, indicating immune crosstalk[8].  \\n\\n---\\n\\n### **5. Integrated Functional Profile**\\n| **Property**               | **Key Genes**         | **Functional Impact**                              |\\n|----------------------------|------------------------|---------------------------------------------------|\\n| **Ciliary Motility**       | CFAP54                | CSF flow, hydrocephalus prevention[1][15]         |\\n| **Vascular Adhesion**      | IGFBP7                | Angiogenesis, TGFβ response[2][12][16]            |\\n| **Amyloid Regulation**     | AQP4, RTN1            | Plaque maturation, BACE1 modulation[4][7]         |\\n| **Pro-Survival Signaling** | LANCL2, VOPP1         | Akt/mTOR activation, anti-apoptosis[3][5]         |\\n| **Non-Coding Regulation**  | MTRNR2L12, DTHD1      | Apoptosis suppression, stress response[8][9][10]  |\\n\\n---\\n\\n### **6. Conclusion**\\nThe gene signature indicates a **specialized ependymal-glial population** with dual roles in:  \\n1. **Homeostasis**: Cilia-mediated CSF dynamics (CFAP54/AQP4) and vascular integrity (IGFBP7).  \\n2. **Pathological Response**:  \\n   - Neurodegeneration: AQP4/IGFBP7 in amyloidosis[4][13], RTN1 in plaque modulation[7].  \\n   - Oncogenesis: VOPP1/LANCL2 in proliferation/survival[3][5].  \\n3. **Microenvironment Interactions**:  \\n   - Immune: MTRNR2L12 fine-tunes B-cell responses[8].  \\n   - Vascular: IGFBP7 bridges ependymal cells and endothelia in angiogenesis[16].  \\n\\nThis profile suggests an **adaptive neuroepithelial compartment** critical for brain fluid dynamics, amyloid pathology, and tumorigenesis, with therapeutic implications for hydrocephalus, AD, and glioma.'},\n",
       "    'delta': {'role': 'assistant', 'content': ''}}]},\n",
       " 'contextual_response': {'id': 'cd1930ab-8fc7-438d-bbbb-e9c5fd55a986',\n",
       "  'model': 'sonar-deep-research',\n",
       "  'created': 1752581943,\n",
       "  'usage': {'prompt_tokens': 153,\n",
       "   'completion_tokens': 3338,\n",
       "   'total_tokens': 3491,\n",
       "   'citation_tokens': 12671,\n",
       "   'num_search_queries': 20,\n",
       "   'reasoning_tokens': 26673},\n",
       "  'citations': ['https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2024.1393253/full',\n",
       "   'https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2020.00048/full',\n",
       "   'https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.758596/text',\n",
       "   'https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2023.1173200/pdf',\n",
       "   'https://journals.plos.org/plosone/article/file?type=supplementary&id=10.1371%2Fjournal.pone.0032917.s003',\n",
       "   'https://www.frontiersin.org/api/v4/articles/937531/file/Table_2.xlsx/937531_supplementary-materials_tables_2_xlsx/2',\n",
       "   'https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0123585',\n",
       "   'https://pubmed.ncbi.nlm.nih.gov/36098369/',\n",
       "   'https://www.frontiersin.org/journals/integrative-neuroscience/articles/10.3389/fnint.2017.00020/full',\n",
       "   'https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.00727/full',\n",
       "   'https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2012.00120/full',\n",
       "   'https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2021.635518/full',\n",
       "   'https://pubmed.ncbi.nlm.nih.gov/25543119/',\n",
       "   'https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126602',\n",
       "   'https://pubmed.ncbi.nlm.nih.gov/35994674/',\n",
       "   'https://pubmed.ncbi.nlm.nih.gov/27002158/',\n",
       "   'https://pubmed.ncbi.nlm.nih.gov/35430380/',\n",
       "   'https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2020.00118/full',\n",
       "   'https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.607587/full'],\n",
       "  'search_results': [{'title': 'Bridging metabolic syndrome and cognitive dysfunction',\n",
       "    'url': 'https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2024.1393253/full',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'Axonal Endoplasmic Reticulum Dynamics and Its Roles in ...',\n",
       "    'url': 'https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2020.00048/full',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'https://www.frontiersin.org/journals/genetics/arti...',\n",
       "    'url': 'https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.758596/text',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'Reactive astrogliosis in the era of single-cell transcriptomics',\n",
       "    'url': 'https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2023.1173200/pdf',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'ranked_gene_list_M_versus_CL...',\n",
       "    'url': 'https://journals.plos.org/plosone/article/file?type=supplementary&id=10.1371%2Fjournal.pone.0032917.s003',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'Table S2 DE-lncRNAs between GU',\n",
       "    'url': 'https://www.frontiersin.org/api/v4/articles/937531/file/Table_2.xlsx/937531_supplementary-materials_tables_2_xlsx/2',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'Periostin Promotes Neural Stem Cell Proliferation and ...',\n",
       "    'url': 'https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0123585',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'Mural Wnt/β-catenin signaling regulates Lama2 expression ...',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/36098369/',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'Region- and Cell-Specific Expression of Transmembrane ...',\n",
       "    'url': 'https://www.frontiersin.org/journals/integrative-neuroscience/articles/10.3389/fnint.2017.00020/full',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'Insulin Growth Factor Binding Protein 7 (IGFBP7)',\n",
       "    'url': 'https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.00727/full',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'Astrocytes as a Source for Extracellular Matrix Molecules ...',\n",
       "    'url': 'https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2012.00120/full',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'ER-PM Contact Sites – SNARING Actors in Emerging ...',\n",
       "    'url': 'https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2021.635518/full',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'Identification of MANF as a protein interacting with RTN1-C',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/25543119/',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'Exome Sequencing Identifies a Mutation in EYA4 as ...',\n",
       "    'url': 'https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126602',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'NAD+ metabolism drives astrocyte proinflammatory ...',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/35994674/',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'Enhancing NAD+ Salvage Pathway Reverts the Toxicity ...',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/27002158/',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'Tenascin-C restricts reactive astrogliosis in the ischemic ...',\n",
       "    'url': 'https://pubmed.ncbi.nlm.nih.gov/35430380/',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'Brain Dysfunction in LAMA2-Related Congenital Muscular ...',\n",
       "    'url': 'https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2020.00118/full',\n",
       "    'date': None,\n",
       "    'last_updated': None},\n",
       "   {'title': 'The Role of Tenascin-C in Tissue Injury and Repair After ...',\n",
       "    'url': 'https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.607587/full',\n",
       "    'date': None,\n",
       "    'last_updated': None}],\n",
       "  'object': 'chat.completion',\n",
       "  'choices': [{'index': 0,\n",
       "    'finish_reason': 'stop',\n",
       "    'message': {'role': 'assistant',\n",
       "     'content': '<think>\\nWe are given a list of genes that are enriched in malignant cells from a glioblastoma patient, and these cells are annotated as \"Astrocyte-gliosis-like\". Our task is to interpret what this gene list might say about the state, properties, and interactions of this cell type. We must consider normal cell biology, development, metabolic states, and interactions beyond just cancer literature.\\n\\nThe genes are: [\\'POSTN\\', \\'JPH1\\', \\'EYA4\\', \\'RTN1\\', \\'LAMA2\\', \\'AC092957.1\\', \\'TNC\\', \\'IGFBP7\\', \\'COL23A1\\', \\'NAMPT\\']\\n\\nWe have search results from various sources that can help us understand the functions of these genes. We will go through each gene and relate it to astrocyte function, reactive astrogliosis, and the context of glioblastoma.\\n\\n1. **POSTN (Periostin)**: \\n   - According to [7], POSTN is a matricellular protein that plays roles in survival, migration, and regeneration. It is expressed in the CNS during development and re-expressed after injury. It promotes neural stem cell (NSC) proliferation and differentiation. In the context of astrocytes, it might be involved in reactive astrogliosis and tissue remodeling. In glioblastoma, this could indicate a role in promoting tumor cell proliferation and invasion.\\n\\n2. **JPH1 (Junctophilin 1)**:\\n   - From [12], junctophilins are involved in forming junctions between the endoplasmic reticulum (ER) and the plasma membrane, which are critical for calcium signaling. JPH1 is expressed in neural tissue and helps in stabilizing calcium microdomains. In astrocytes, calcium signaling is vital for their function. In the context of glioblastoma, dysregulation of calcium signaling might contribute to tumor cell survival and migration.\\n\\n3. **EYA4 (Eyes Absent Homolog 4)**:\\n   - [14] indicates that EYA4 is a transcriptional coactivator involved in developmental processes, including in the nervous system. Mutations in EYA4 are associated with hearing loss, but its role in astrocytes is less clear. It might be involved in developmental pathways that are reactivated in cancer. In glioblastoma, it could contribute to aberrant transcriptional programs.\\n\\n4. **RTN1 (Reticulon 1)**:\\n   - [2] and [13] discuss reticulons (RTNs) as ER-shaping proteins. RTN1-C interacts with MANF (mesencephalic astrocyte-derived neurotrophic factor), which is important for neuronal survival and ER stress responses [13]. In astrocytes, RTN1 might be involved in ER remodeling during stress. In glioblastoma, ER stress responses are often dysregulated, promoting survival under stress.\\n\\n5. **LAMA2 (Laminin Subunit Alpha 2)**:\\n   - [18] describes LAMA2 as a component of laminins in the extracellular matrix (ECM), particularly in the basement membrane. It is crucial for blood-brain barrier (BBB) integrity and is produced by astrocytes. In glioblastoma, LAMA2 might contribute to the abnormal ECM that supports tumor invasion and angiogenesis.\\n\\n6. **AC092957.1**:\\n   - This appears to be a long non-coding RNA (lncRNA). From [3] and [6], we see that AC092957.1 is mentioned in the context of genomic instability in low-grade gliomas (LGGs). LncRNAs can regulate gene expression epigenetically. In astrocytes, it might be involved in the regulation of reactive responses. In cancer, lncRNAs often contribute to oncogenic pathways.\\n\\n7. **TNC (Tenascin C)**:\\n   - [11] and [17] highlight TNC as an ECM glycoprotein produced by reactive astrocytes. It is involved in development and injury responses, acting as a modulator of cell adhesion and migration. In glioblastoma, TNC is often upregulated and associated with poor prognosis, promoting invasion and resistance to therapy.\\n\\n8. **IGFBP7 (Insulin-like Growth Factor Binding Protein 7)**:\\n   - [10] shows that IGFBP7 is downregulated in some cancers (like hepatocellular carcinoma) but may have context-dependent roles. It can act as a tumor suppressor by inducing senescence. In astrocytes, IGFBP7 might regulate responses to growth factors. In glioblastoma, it could be involved in autocrine/paracrine signaling.\\n\\n9. **COL23A1 (Collagen Type XXIII Alpha 1 Chain)**:\\n   - [9] indicates that COL23A1 is a transmembrane collagen expressed by neurons in specific brain regions (like the accessory olfactory bulb). Its role in astrocytes is not well-established, but it might be involved in cell-matrix interactions. In cancer, collagens can influence tumor progression.\\n\\n10. **NAMPT (Nicotinamide Phosphoribosyltransferase)**:\\n    - [15] and [16] discuss NAMPT as the rate-limiting enzyme in the NAD+ salvage pathway. Astrocytes use NAD+ for energy and immune responses. In [15], NAMPT is crucial for proinflammatory astrocyte activation. In glioblastoma, increased NAD+ metabolism might support tumor growth and resistance to stress.\\n\\nNow, integrating these genes into a cohesive picture of the \"Astrocyte-gliosis-like\" malignant cells:\\n\\n- **Reactive Astrocyte Signature**: The presence of TNC, POSTN, and LAMA2 suggests an extracellular matrix remodeling phenotype, typical of reactive astrocytes. This is further supported by COL23A1 (a collagen) and IGFBP7 (an ECM-associated protein). These genes indicate that the cells are producing an abnormal ECM that may facilitate invasion and angiogenesis.\\n\\n- **Calcium and ER Dynamics**: JPH1 and RTN1 point towards dysregulated calcium signaling and ER morphology. In reactive astrocytes, calcium waves are important for intercellular communication. In cancer, altered calcium signaling can promote proliferation and migration.\\n\\n- **Metabolic Reprogramming**: NAMPT is key in NAD+ metabolism. Reactive astrocytes often undergo metabolic shifts (e.g., towards glycolysis), and NAD+ is crucial for energy production and inflammation. In glioblastoma, this might support the high metabolic demands of tumor cells and modulate the tumor microenvironment.\\n\\n- **Developmental Pathways**: EYA4 is a transcriptional coactivator involved in development. Its re-expression in cancer might reactivate developmental programs that drive stem-like properties (e.g., in neural stem cells). This is consistent with the glioblastoma stem cell hypothesis.\\n\\n- **Non-coding RNA**: AC092957.1, as a lncRNA, might regulate these pathways epigenetically. LncRNAs can control chromatin states and gene expression, potentially maintaining the tumor-promoting state.\\n\\n- **Cross-cutting Metabolic States**: The NAD+ pathway (via NAMPT) links to cellular energetics and redox balance. Reactive astrocytes in glioblastoma might use NAD+ to fuel proinflammatory responses and resist oxidative stress.\\n\\n- **Cell-Cell Interactions**: \\n  - Astrocytes normally interact with neurons, endothelial cells, and microglia. \\n  - TNC and POSTN can modulate interactions with the ECM and other cells (e.g., immune cells). \\n  - LAMA2 is critical for BBB integrity; its dysregulation might contribute to BBB breakdown in glioblastoma, facilitating immune cell infiltration and tumor spread.\\n  - IGFBP7 might mediate interactions with growth factors (e.g., IGFs) in the microenvironment.\\n\\n- **Gliosis in Cancer**: Reactive astrogliosis is a response to injury, but in glioblastoma, this response is co-opted to support tumor growth. The gene list suggests a chronic, maladaptive gliosis that promotes tumor progression via ECM remodeling, altered metabolism, and dysregulated signaling.\\n\\nIn conclusion, the gene signature indicates that the \"Astrocyte-gliosis-like\" malignant cells in glioblastoma exhibit:\\n- A reactive ECM-remodeling phenotype (TNC, POSTN, LAMA2, COL23A1, IGFBP7)\\n- Altered intracellular signaling (JPH1, RTN1, EYA4)\\n- Metabolic adaptation with a focus on NAD+ metabolism (NAMPT)\\n- Epigenetic regulation (AC092957.1)\\n\\nThese properties likely contribute to tumor invasion, immune evasion, and resistance to therapy. The state resembles a chronic, non-resolving gliotic response that supports tumor growth.\\n\\nWe will now structure the report accordingly.\\n</think>\\n### Enriched Gene Signature in Glioblastoma Astrocyte-Gliosis-Like Malignant Cells: Implications for Cellular State, Interactions, and Metabolic Reprogramming  \\n\\nThe gene signature identified in malignant astrocyte-gliosis-like cells from glioblastoma patients—comprising **POSTN**, **JPH1**, **EYA4**, **RTN1**, **LAMA2**, **AC092957.1**, **TNC**, **IGFBP7**, **COL23A1**, and **NAMPT**—reveals a multifaceted cellular phenotype rooted in extracellular matrix (ECM) remodeling, metabolic dysregulation, and aberrant developmental signaling. This profile mirrors conserved astrocytic responses to injury, metabolic stress, and developmental pathways, now co-opted in malignancy. Below, we dissect the implications across cellular states, interactions, and metabolic adaptations, integrating insights from neurodevelopment, homeostasis, and disease contexts.  \\n\\n---\\n\\n### ECM Remodeling and Structural Dysregulation  \\nAstrocyte-gliosis-like cells exhibit pronounced ECM dysregulation, driven by:  \\n- **Tenascin-C (TNC)**: A key ECM glycoprotein re-expressed in reactive astrocytes under pathological conditions. TNC restricts astrogliosis and modulates astrocyte-microglial crosstalk, but in glioblastoma, its overexpression may facilitate invasive tumor growth by disrupting normal tissue architecture[11][17]. TNC\\'s interaction with fibronectin domains and L-type Ca²⁺ channels further implicates it in calcium signaling dysregulation, a hallmark of glioma progression[11][17].  \\n- **Periostin (POSTN)**: This matricellular protein promotes neural stem cell proliferation and differentiation. In glioblastoma, POSTN likely drives tumor expansion by enhancing cell adhesion, ECM deposition, and activation of integrin-mediated pathways[7]. Its homology to fasciclin I suggests roles in neurite outgrowth, potentially enabling network integration of malignant cells[7].  \\n- **Laminin-α2 (LAMA2)**: Critical for blood-brain barrier (BBB) integrity, LAMA2 anchors astrocytes to endothelial cells via dystroglycan and α7β1 integrins. Loss of LAMA2 in neurovascular units correlates with BBB dysfunction, pericyte detachment, and reactive gliosis—features exacerbated in glioblastoma to promote angiogenesis and immune infiltration[18][8].  \\n- **Collagen XXII Alpha 1 (COL23A1)**: A transmembrane collagen enriched in neuronal layers (e.g., mitral/tufted cells of the olfactory bulb). Its presence in glioblastoma implies aberrant re-activation of developmental collagen pathways, potentially altering cell-ECM signaling and tissue stiffness[9].  \\n\\n---\\n\\n### Intracellular Signaling and Organelle Dynamics  \\nDysregulation of endoplasmic reticulum (ER) and calcium homeostasis underpins malignant transformation:  \\n- **Reticulon-1 (RTN1)**: Shapes ER tubules and modulates ER stress responses. RTN1-C interacts with mesencephalic astrocyte-derived neurotrophic factor (MANF), linking ER integrity to neuroprotection. In glioblastoma, RTN1 may drive adaptive ER expansion to support protein synthesis and stress survival[2][13].  \\n- **Junctophilin-1 (JPH1)**: Tethers ER to the plasma membrane to regulate Ca²⁺ microdomains. JPH1 stabilizes Cav1-RyR2-KCa3.1 complexes in neurons; its dysregulation in astrocytes could disrupt Ca²⁺-dependent gliotransmission, promoting excitotoxicity and tumor invasion[12].  \\n\\n---\\n\\n### Metabolic Reprogramming  \\nNAD⁺ salvage pathway activation fuels proinflammatory and survival pathways:  \\n- **Nicotinamide Phosphoribosyltransferase (NAMPT)**: The rate-limiting enzyme in NAD⁺ biosynthesis. NAMPT upregulation in reactive astrocytes drives glycolysis and oxidative phosphorylation, supporting inflammatory gene transcription via CD38/NFAT signaling. In glioblastoma, this sustains tumor energy demands and evasion of oxidative stress[15][16].  \\n- **Insulin-like Growth Factor Binding Protein 7 (IGFBP7)**: A senescence inducer downregulated in cancers. IGFBP7 binds activin A and heparan sulfate, modulating TGF-β signaling. Its loss in glioblastoma may disable tumor-suppressive ECM cues, while its re-expression could impair angiogenesis[10].  \\n\\n---\\n\\n### Developmental and Epigenetic Reawakening  \\nGenes typifying neural development are aberrantly activated:  \\n- **Eyes Absent Homolog 4 (EYA4)**: A transcriptional co-activator in sensory development. EYA4 mutations cause hearing loss via disrupted neurodevelopment. In glioblastoma, EYA4 may reactivate stemness programs, fostering dedifferentiation[14].  \\n- **Long Non-Coding RNA AC092957.1**: Associated with genomic instability in gliomas. lncRNAs like AC092957.1 can silence tumor suppressors or amplify oncogenic pathways, contributing to the \"astrocyte-gliosis\" epigenetic landscape[3][6].  \\n\\n---\\n\\n### Cross-Tissue Interactions  \\nGliosis-like malignant cells engage in pathological crosstalk:  \\n- **Neuron-Astrocyte Axis**: Calcium dysregulation (JPH1) and ECM disruption (TNC, POSTN) impair synaptic stability. TNC-mediated phagocytic pruning of synapses may be hijacked to eliminate neuronal inhibition of tumor growth[1][17].  \\n- **Microglia and Immune Cells**: TNC and IGFBP7 modulate cytokine release (e.g., via NF-κB), recruiting microglia. NAD⁺-driven astrocyte inflammation (NAMPT) further polarizes immune cells toward tumor tolerance[11][15][17].  \\n- **Vascular Niche**: LAMA2 loss and TNC overexpression degrade BBB tight junctions, facilitating angiogenesis. Hypoxia-inducible factors (e.g., HIF-1α) may synergize with NAMPT to fuel metabolic adaptation in perivascular niches[8][15][18].  \\n\\n---\\n\\n### Metabolic State Integration  \\nAstrocyte-gliosis-like cells exhibit a \"Warburg-like\" metabolic shift:  \\n1. **Glycolytic Flux**: NAMPT-driven NAD⁺ recycling enhances glycolysis, supplying ATP for phagocytic and inflammatory activity—mirroring reactive astrocytes in neurodegeneration[1][15].  \\n2. **Lipid and Protein Stress**: RTN1 and JPH1 alter ER morphology, disrupting lipid metabolism and protein folding. This may activate unfolded protein responses, increasing chaperone expression (e.g., HSP90)[4][12].  \\n3. **Redox Imbalance**: NAD⁺ depletion amplifies oxidative stress. Paradoxically, NAMPT upregulation may counter this by fueling antioxidant pathways, illustrating a metabolic trade-off in malignancy[16].  \\n\\n---\\n\\n### Conclusion  \\nThe enriched gene signature in astrocyte-gliosis-like glioblastoma cells depicts a maladaptive state where developmental, metabolic, and structural programs converge. Key features include:  \\n- **ECM Dysplasia**: TNC, POSTN, and LAMA2 create a tumor-permissive matrix.  \\n- **Metabolic Plasticity**: NAMPT sustains inflammation and stress resilience.  \\n- **Developmental Reversion**: EYA4 and AC092957.1 reawaken neural stem cell-like traits.  \\n- **Network Dysfunction**: Altered ER/calcium dynamics (RTN1, JPH1) and immune crosstalk drive progression.  \\n\\nThis phenotype mirrors conserved astrocyte responses to injury but is locked in a self-amplifying loop of invasion and metabolic opportunism. Targeting NAMPT or TNC may disrupt this equilibrium, offering therapeutic entry points[11][15][17]. Future work should explore single-cell spatial transcriptomics to deconvolute heterogeneous glioblastoma microenvironments.'},\n",
       "    'delta': {'role': 'assistant', 'content': ''}}]}}"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "results[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "79a13a34-72fb-4ac7-bfc9-ba7f18b567a1",
   "metadata": {},
   "outputs": [],
   "source": [
    "def gen_bib(citations):\n",
    "    \"\"\"\n",
    "    Corrected function to format a list of citation URLs into a Markdown list.\n",
    "    \"\"\"\n",
    "    if not citations:\n",
    "        return \"## References\\n\\nNo citations provided.\"\n",
    "        \n",
    "    out = ['\\n\\n## References\\n']\n",
    "    # The citations are a list of URL strings, so we iterate through them directly.\n",
    "    for i, url in enumerate(citations):\n",
    "        out.append(f\"- [{i+1}] {url}\") # Format each URL as a list item\n",
    "        \n",
    "    return '\\n'.join(out)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "59fec9de-11de-4edd-8e18-c193bf2cae0c",
   "metadata": {},
   "outputs": [],
   "source": [
    "def rep(row, typ):\n",
    "    \"\"\"Creates one section of a report (plain or contextual).\"\"\"\n",
    "    response_data = row.get(f'{typ}_response', {})\n",
    "    \n",
    "    # Check for errors first\n",
    "    if \"error\" in response_data or 'choices' not in response_data:\n",
    "        error_message = response_data.get(\"error\", \"Unknown error: Response format is incorrect.\")\n",
    "        return f\"## {typ.capitalize()} Query Report: {row['annotation_granular']}\\n\\n**Error:**\\n```\\n{error_message}\\n```\"\n",
    "\n",
    "    # Safely get content and citations\n",
    "    content = response_data['choices'][0]['message'].get('content', 'No content found.')\n",
    "    citations_list = response_data.get('citations', [])\n",
    "    \n",
    "    # Build the report section\n",
    "    title = f\"## {typ.capitalize()} Query Report: {row['annotation_granular']}\"\n",
    "    query_text = f\"**Query:**\\n> {row[f'{typ}_query']}\"\n",
    "    bibliography = gen_bib(citations_list)\n",
    "    \n",
    "    return \"\\n\\n\".join([title, query_text, \"**Response:**\\n\" + content, bibliography])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "4f77dfe3-9583-4cba-a04b-2aa7c2ad08b5",
   "metadata": {},
   "outputs": [],
   "source": [
    "def generate_report(row):\n",
    "    \"\"\"Generates a complete, formatted Markdown report for a single row.\"\"\"\n",
    "    # Combine the plain and contextual sections into one report\n",
    "    plain_section = rep(row, typ='plain')\n",
    "    contextual_section = rep(row, typ='contextual')\n",
    "    \n",
    "    main_title = f\"# Full Report for: {row['annotation_granular']}\"\n",
    "    return f\"{main_title}\\n\\n---\\n\\n{plain_section}\\n\\n---\\n\\n{contextual_section}\"\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "f3b7a787-3614-4715-8245-d43a229901a4",
   "metadata": {},
   "outputs": [],
   "source": [
    "def generate_and_save_all_reports(records, directory_path):\n",
    "    \"\"\"\n",
    "    Generates and saves separate plain and contextual reports for each record.\n",
    "    \"\"\"\n",
    "    # Create the target directory if it doesn't exist\n",
    "    os.makedirs(directory_path, exist_ok=True)\n",
    "    print(f\"Saving separate reports to: {directory_path}\")\n",
    "\n",
    "    for r in records:\n",
    "        # --- Save the Plain Report ---\n",
    "        plain_filename = f\"{r['annotation_granular'].replace(' ', '_')}_plain.md\"\n",
    "        plain_path = os.path.join(directory_path, plain_filename)\n",
    "        plain_content = rep(r, typ='plain') # Get only the plain section\n",
    "        \n",
    "        with open(plain_path, 'w', encoding='utf-8') as file:\n",
    "            file.write(plain_content)\n",
    "\n",
    "        # --- Save the Contextual Report ---\n",
    "        contextual_filename = f\"{r['annotation_granular'].replace(' ', '_')}_contextual.md\"\n",
    "        contextual_path = os.path.join(directory_path, contextual_filename)\n",
    "        contextual_content = rep(r, typ='contextual') # Get only the contextual section\n",
    "\n",
    "        with open(contextual_path, 'w', encoding='utf-8') as file:\n",
    "            file.write(contextual_content)\n",
    "            \n",
    "    print(\"All separate reports have been saved successfully.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "ce5a44af-66dd-471f-b6ff-e2fea6a5dc1f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "--- Generating a single report preview ---\n",
      "# Full Report for: AC-gliosis-like 1\n",
      "\n",
      "---\n",
      "\n",
      "## Plain Query Report: AC-gliosis-like 1\n",
      "\n",
      "**Query:**\n",
      "> What might the following enriched gene lists say about the type, properties and cell-cell interactions of the cells the list was derived from ['POSTN', 'JPH1', 'EYA4', 'RTN1', 'LAMA2', 'AC092957.1', 'TNC', 'IGFBP7', 'COL23A1', 'NAMPT']\n",
      "\n",
      "**Response:**\n",
      "<think>\n",
      "We are given a list of genes: ['CFAP54', 'IGFBP7', 'VOPP1', 'AQP4', 'LANCL2', 'AC074351.1', 'DTHD1', 'AC012405.1', 'RTN1', 'MTRNR2L12'].\n",
      "\n",
      "We are to analyze what this enriched gene list might say about the type, properties, and cell-cell interactions of the cells from which the list was derived.\n",
      "\n",
      "### Step 1: Understand the function of each gene\n",
      "\n",
      "We have several genes. We will use the provided search results to understand each gene's function and relevance.\n",
      "\n",
      "1. **CFAP54**: From search result [1], CFAP54 is required for proper ciliary motility and assembly. Mutations in CFAP54 lead to defects in the C1d projection of cilia, resulting in decreased ciliary beat frequency and perturbed cilia-driven flow. It is associated with primary ciliary dyskinesia (PCD). In [15], CFAP54 mutations cause reduced ependymal ciliary beating frequency and loss of the C1d projection. Ependymal cilia are important for cerebrospinal fluid (CSF) flow.\n",
      "\n",
      "2. **IGFBP7**: From [2], [12], [13], and [16], IGFBP7 is an insulin-like growth factor binding protein that is expressed in various tissues, including endothelial cells, and plays roles in angiogenesis, cell adhesion, and tumor suppression. It is also implicated in Alzheimer's disease and memory function. In [2], it is present in glandular epithelial cells and stromal cells. In [12], IGFBP7 is upregulated in vasculature in response to brain injury and is associated with TGFβ signaling. In [13], it is involved in memory and Alzheimer's disease. In [16], it is crucial in lumen formation during angiogenesis and has anti-inflammatory and anti-fibrotic properties.\n",
      "\n",
      "3. **VOPP1**: From [3], VOPP1 (Vesicular overexpressed in cancer pro-survival protein 1) is overexpressed in several cancers and promotes cell proliferation and survival by targeting the MAPK and mTOR pathways. It is associated with hepatocellular carcinoma (HCC) progression.\n",
      "\n",
      "4. **AQP4**: From [4], [17], AQP4 is an aquaporin water channel that is highly expressed in astrocyte endfeet and ependymal cells. It plays a role in water homeostasis in the brain and is associated with amyloid deposition in Alzheimer's disease. In [17], AQP4 maintains ependymal integrity and is involved in CSF production and brain water content.\n",
      "\n",
      "5. **LANCL2**: From [5], LANCL2 is a positive regulator of Akt activation. It directly interacts with Akt and mTORC2, enhancing Akt phosphorylation. It promotes cell survival and inhibits apoptosis.\n",
      "\n",
      "6. **AC074351.1**: Not explicitly mentioned in the provided search results. This appears to be a non-coding RNA or a gene with an accession number. Without specific information, we might infer from the context of other genes.\n",
      "\n",
      "7. **DTHD1**: From [6], [9], [10], and [11], DTHD1 is a gene that has been associated with Alzheimer's disease as a potential biomarker (downregulated in AD) and also with retinal dystrophy and hepatocellular carcinoma. In [9], DTHD1 is a target of miR-3131 in HCC. In [10], DTHD1 is identified as a potential candidate in glioblastoma. In [11], DTHD1 is a candidate disease gene for retinal dystrophy.\n",
      "\n",
      "8. **AC012405.1**: Not explicitly mentioned. This is another accession number, likely a non-coding RNA or uncharacterized gene.\n",
      "\n",
      "9. **RTN1**: From [7], RTN1 is a reticulon protein that interacts with BACE1 and modulates its secretase activity. It is differentially expressed in Alzheimer's brains and is localized in dendrites. RTN1 and RTN3 have differential effects on senile plaques.\n",
      "\n",
      "10. **MTRNR2L12**: From [8], MTRNR2L12 is a long non-coding RNA (lncRNA) that is anti-apoptotic. It is downregulated in B cells after vaccination and is associated with cellular stress. Low expression may be associated with reduced adverse vaccine reactions.\n",
      "\n",
      "### Step 2: Identify common themes and cell types\n",
      "\n",
      "- **Cilia and Ependymal Cells**: CFAP54 is critical for ciliary function and is expressed in ependymal cells. AQP4 is also expressed in ependymal cells and maintains their integrity. Both are involved in CSF dynamics. This suggests that the cell type might have ciliated ependymal cells or be related to the ventricular system.\n",
      "\n",
      "- **Angiogenesis and Endothelial Cells**: IGFBP7 is expressed in endothelial cells and is involved in angiogenesis and response to injury. AQP4 is also found in astrocyte endfeet which are in close contact with endothelial cells. This suggests a vascular component.\n",
      "\n",
      "- **Neurodegeneration and Gliopathies**: AQP4 is associated with amyloid deposition in Alzheimer's disease and astrocyte pathology. RTN1 is involved in Alzheimer's disease via modulation of BACE1. IGFBP7 is implicated in Alzheimer's disease and memory. DTHD1 is linked to Alzheimer's as a biomarker. This points to a role in neurodegenerative conditions.\n",
      "\n",
      "- **Cancer and Proliferation**: VOPP1 promotes proliferation in cancer. LANCL2 promotes cell survival via Akt. IGFBP7 has both tumor suppressor and promoter roles depending on context. DTHD1 is linked to cancer (HCC). This suggests proliferative and survival properties.\n",
      "\n",
      "- **Non-coding RNAs**: AC074351.1 and AC012405.1 are not characterized in the provided data, but MTRNR2L12 is an anti-apoptotic lncRNA. This indicates regulatory roles at the RNA level.\n",
      "\n",
      "- **Stress Response and Apoptosis**: MTRNR2L12 is anti-apoptotic and associated with cellular stress. LANCL2 is anti-apoptotic via Akt. IGFBP7 can induce apoptosis in some contexts.\n",
      "\n",
      "### Step 3: Synthesize the cell type and properties\n",
      "\n",
      "Given the genes:\n",
      "\n",
      "- The presence of genes associated with ependymal cells (CFAP54, AQP4) and ciliary function suggests that the cells are likely **ependymal cells** or cells with ciliary functions. Given the importance of ependymal cilia in CSF flow and the involvement of AQP4 in ependymal integrity, this is a strong candidate.\n",
      "\n",
      "- Additionally, the involvement in neurodegenerative pathways (AQP4, RTN1, IGFBP7, DTHD1) and angiogenesis (IGFBP7) might indicate that these cells are in an environment of brain injury or neuroinflammation, such as in the context of astrocytoma or glioblastoma (as IGFBP7 is also implicated in glioma, see [14]).\n",
      "\n",
      "- The expression of genes related to proliferation and survival (VOPP1, LANCL2) might suggest a proliferative state, which is characteristic of cancer cells, but in the context of the brain, this could be in glioma.\n",
      "\n",
      "- The presence of non-coding RNAs (MTRNR2L12, and possibly AC074351.1 and AC012405.1) indicates regulatory functions, which are common in complex cellular responses.\n",
      "\n",
      "Therefore, the enriched gene list likely comes from **ependymal cells or ependymal cell-related conditions, possibly in a context of injury, neurodegeneration, or neoplasia (like glioma)**.\n",
      "\n",
      "### Step 4: Cell-cell interactions\n",
      "\n",
      "- **Cilia-Driven CSF Flow**: Ependymal cells with functional cilia (requiring CFAP54) interact with the CSF and help in its flow. This affects the entire ventricular system and brain.\n",
      "\n",
      "- **Vascular Interactions**: IGFBP7 is expressed in endothelial cells and may mediate interactions between ependymal cells and the vasculature. AQP4 is in ependymal cells and also in astrocyte endfeet, suggesting interactions with astrocytes and blood vessels.\n",
      "\n",
      "- **Neurodegeneration and Glial Interactions**: In Alzheimer's disease, AQP4 and IGFBP7 are associated with amyloid deposition and astrocyte pathology. RTN1 is involved in plaque formation. This suggests interactions with neurons and astrocytes.\n",
      "\n",
      "- **Immune and Inflammatory Responses**: IGFBP7 has anti-inflammatory properties. MTRNR2L12 is associated with stress and immune responses (vaccination context). This might indicate interactions with immune cells.\n",
      "\n",
      "- **Tumor Microenvironment**: In glioma (as per [14]), IGFBP7+ cells are a subpopulation that influences astrocytoma progression. This suggests interactions within the tumor microenvironment, including with other glioma cells and possibly immune cells.\n",
      "\n",
      "### Conclusion\n",
      "\n",
      "The gene list suggests that the cells are likely **ependymal cells** or cells in the ependymal lineage, possibly in a state of activation due to injury, neurodegeneration, or neoplasia (such as glioma). The properties include:\n",
      "\n",
      "1. **Ciliary function and CSF dynamics** (CFAP54, AQP4)\n",
      "2. **Angiogenesis and vascular interactions** (IGFBP7)\n",
      "3. **Neurodegeneration and plaque formation** (AQP4, RTN1, IGFBP7, DTHD1)\n",
      "4. **Cell survival and proliferation** (LANCL2, VOPP1, MTRNR2L12)\n",
      "5. **Regulatory non-coding RNAs** (MTRNR2L12, AC074351.1, AC012405.1)\n",
      "\n",
      "Cell-cell interactions involve:\n",
      "\n",
      "- Interactions with CSF and the ventricular system via cilia.\n",
      "- Interactions with the vasculature and astrocytes (via AQP4 and IGFBP7).\n",
      "- In pathological contexts (like glioma), interactions within the tumor microenvironment.\n",
      "\n",
      "This analysis is based on the provided search results and the known functions of the genes.\n",
      "</think>\n",
      "Based on the enriched gene list (CFAP54, IGFBP7, VOPP1, AQP4, LANCL2, AC074351.1, DTHD1, AC012405.1, RTN1, MTRNR2L12) and extensive analysis of the provided research context, the cells exhibit properties characteristic of **ependymal cells and glial-vascular interface cells in neurodegenerative and oncological contexts**. Below is a comprehensive analysis of cell type, properties, and cell-cell interactions:\n",
      "\n",
      "---\n",
      "\n",
      "### **1. Ependymal Cell Identity and Ciliary Function**\n",
      "- **CFAP54-Dependent Cilia Assembly**:  \n",
      "  CFAP54 is essential for proper ciliary motility and structural integrity in ependymal cells[1][15]. Mutations cause loss of the C1d projection in motile cilia, reducing ciliary beat frequency and disrupting cerebrospinal fluid (CSF) flow[1]. This leads to hydrocephalus due to impaired CSF circulation[15].  \n",
      "- **AQP4 in Ependymal Integrity**:  \n",
      "  AQP4 maintains ependymal cell polarization and structural integrity by anchoring to basolateral membranes. AQP4 deficiency disrupts gap junctions (e.g., connexin43), reducing CSF production and increasing brain water content[17].  \n",
      "\n",
      "**Properties**:  \n",
      "- **Motile Cilia Density**: ~50 cilia per cell with \"9+2\" microtubule arrays[15].  \n",
      "- **Polarized Organization**: Basal bodies exhibit rotational polarity for coordinated ciliary beating[15].  \n",
      "- **CSF Dynamics**: Cilia drive directional CSF flow from lateral ventricles to subarachnoid space[15].  \n",
      "\n",
      "---\n",
      "\n",
      "### **2. Neurodegenerative and Gliovascular Roles**\n",
      "#### **A. IGFBP7 in Vasculature and Astrocyte Crosstalk**\n",
      "- **TGFβ-Mediated Upregulation**:  \n",
      "  IGFBP7 is upregulated in endothelial cells (ECs) upon TGFβ stimulation, particularly after brain injury or in Alzheimer's disease (AD) pathology[12][16]. It localizes to vascular basement membranes and binds collagen IV, facilitating EC adhesion and angiogenesis[2][16].  \n",
      "- **AD Biomarker**:  \n",
      "  IGFBP7 elevation in AD impairs memory consolidation and is linked to amyloid deposition. Blocking IGFBP7 restores memory function in AD models[13].  \n",
      "\n",
      "#### **B. AQP4 in Amyloid Pathology**\n",
      "- **Plaque-Associated Redistribution**:  \n",
      "  AQP4 redistributes to astrocyte processes surrounding amyloid plaques in AD, correlating with plaque maturation stages[4]. This suggests AQP4 facilitates amyloid-β aggregation and glial activation[4][17].  \n",
      "\n",
      "#### **C. RTN1 in Neuronal Integrity**\n",
      "- **Dendritic Localization**:  \n",
      "  RTN1 marks dendrites (e.g., Purkinje cells) and modulates BACE1 activity, influencing amyloidogenesis. Unlike RTN3, it is not enriched in dystrophic neurites around plaques[7].  \n",
      "\n",
      "**Properties**:  \n",
      "- **Stress-Responsive Secretome**: IGFBP7 and AQP4 respond to hypoxia/TGFβ in injury[12][16].  \n",
      "- **Barrier Functions**: AQP4 and IGFBP7 regulate blood-brain barrier (BBB) permeability and ion/water homeostasis[4][17].  \n",
      "\n",
      "---\n",
      "\n",
      "### **3. Oncogenic and Survival Pathways**\n",
      "#### **A. Pro-Survival Signaling**\n",
      "- **LANCL2-Akt-mTOR Axis**:  \n",
      "  LANCL2 directly binds Akt and mTORC2, enhancing Akt phosphorylation and inhibiting apoptosis[5]. This pathway promotes cell survival in neural and hepatic contexts[5][9].  \n",
      "- **VOPP1 in Tumor Progression**:  \n",
      "  VOPP1 upregulation in hepatocellular carcinoma (HCC) activates MAPK/mTOR pathways, driving proliferation and tumor growth[3].  \n",
      "\n",
      "#### **B. Non-Coding RNA Regulation**\n",
      "- **MTRNR2L12 (Anti-Apoptotic lncRNA)**:  \n",
      "  This lncRNA suppresses apoptosis and correlates with cellular stress. Downregulation reduces adverse inflammatory reactions (e.g., post-vaccination)[8].  \n",
      "- **AC074351.1 and AC012405.1**:  \n",
      "  These unannotated RNAs may regulate stress responses or epigenetic remodeling, similar to MTRNR2L12[8][10].  \n",
      "\n",
      "**Properties**:  \n",
      "- **Therapeutic Targets**: LANCL2/VOPP1 are candidate targets for cancer therapy[3][5].  \n",
      "- **Stress Adaptation**: MTRNR2L12 buffers against oxidative or inflammatory stress[8].  \n",
      "\n",
      "---\n",
      "\n",
      "### **4. Cell-Cell Interactions**\n",
      "#### **A. Ependymal-Vascular Interface**\n",
      "- **IGFBP7-Mediated Angiogenesis**:  \n",
      "  IGFBP7 secretion by ependymal/ECs stimulates endothelial adhesion to collagen IV, promoting vascular lumen formation[16]. In injury, TGFβ from microglia/ECs upregulates IGFBP7, enhancing BBB repair[12].  \n",
      "- **Cilia-Driven Nutrient Exchange**:  \n",
      "  Ependymal cilia facilitate CSF-mediated nutrient/waste exchange with parenchymal vessels[15].  \n",
      "\n",
      "#### **B. Neuroglial Interactions in Pathology**\n",
      "- **Amyloid Clearance Coordination**:  \n",
      "  AQP4[4] and IGFBP7[13] on astrocytes interact with amyloid plaques, while ependymal cilia drive glymphatic CSF flow for clearance[15].  \n",
      "- **Tumor Microenvironment**:  \n",
      "  In glioma, IGFBP7+ subpopulations (C0) influence astrocytoma differentiation and prognosis via FAM20C/TIMP1 expression[14].  \n",
      "\n",
      "#### **C. Immune Modulation**\n",
      "- **MTRNR2L12 in B Cells**:  \n",
      "  Downregulation in B cells post-vaccination correlates with reduced adverse reactions, indicating immune crosstalk[8].  \n",
      "\n",
      "---\n",
      "\n",
      "### **5. Integrated Functional Profile**\n",
      "| **Property**               | **Key Genes**         | **Functional Impact**                              |\n",
      "|----------------------------|------------------------|---------------------------------------------------|\n",
      "| **Ciliary Motility**       | CFAP54                | CSF flow, hydrocephalus prevention[1][15]         |\n",
      "| **Vascular Adhesion**      | IGFBP7                | Angiogenesis, TGFβ response[2][12][16]            |\n",
      "| **Amyloid Regulation**     | AQP4, RTN1            | Plaque maturation, BACE1 modulation[4][7]         |\n",
      "| **Pro-Survival Signaling** | LANCL2, VOPP1         | Akt/mTOR activation, anti-apoptosis[3][5]         |\n",
      "| **Non-Coding Regulation**  | MTRNR2L12, DTHD1      | Apoptosis suppression, stress response[8][9][10]  |\n",
      "\n",
      "---\n",
      "\n",
      "### **6. Conclusion**\n",
      "The gene signature indicates a **specialized ependymal-glial population** with dual roles in:  \n",
      "1. **Homeostasis**: Cilia-mediated CSF dynamics (CFAP54/AQP4) and vascular integrity (IGFBP7).  \n",
      "2. **Pathological Response**:  \n",
      "   - Neurodegeneration: AQP4/IGFBP7 in amyloidosis[4][13], RTN1 in plaque modulation[7].  \n",
      "   - Oncogenesis: VOPP1/LANCL2 in proliferation/survival[3][5].  \n",
      "3. **Microenvironment Interactions**:  \n",
      "   - Immune: MTRNR2L12 fine-tunes B-cell responses[8].  \n",
      "   - Vascular: IGFBP7 bridges ependymal cells and endothelia in angiogenesis[16].  \n",
      "\n",
      "This profile suggests an **adaptive neuroepithelial compartment** critical for brain fluid dynamics, amyloid pathology, and tumorigenesis, with therapeutic implications for hydrocephalus, AD, and glioma.\n",
      "\n",
      "\n",
      "\n",
      "## References\n",
      "\n",
      "- [1] https://pubmed.ncbi.nlm.nih.gov/26224312/\n",
      "- [2] https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2024.1420862/full\n",
      "- [3] https://pubmed.ncbi.nlm.nih.gov/32083568/\n",
      "- [4] https://pubmed.ncbi.nlm.nih.gov/28222512/\n",
      "- [5] https://pubmed.ncbi.nlm.nih.gov/25273559/\n",
      "- [6] https://pubmed.ncbi.nlm.nih.gov/39433822/\n",
      "- [7] https://pubmed.ncbi.nlm.nih.gov/28733667/\n",
      "- [8] https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1131051/full\n",
      "- [9] https://pubmed.ncbi.nlm.nih.gov/28034876/\n",
      "- [10] https://pubmed.ncbi.nlm.nih.gov/34180136/\n",
      "- [11] https://pubmed.ncbi.nlm.nih.gov/23105016/\n",
      "- [12] https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2020.599834/full\n",
      "- [13] https://en.wikipedia.org/wiki/IGFBP7\n",
      "- [14] https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1434300/full\n",
      "- [15] https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.927479/full\n",
      "- [16] https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2024.1421438/full\n",
      "- [17] https://pubmed.ncbi.nlm.nih.gov/19393298/\n",
      "\n",
      "---\n",
      "\n",
      "## Contextual Query Report: AC-gliosis-like 1\n",
      "\n",
      "**Query:**\n",
      "> The following is a list of genes enriched in Malignant cells from a (human) patient with glioblastoma  annotated as Astrocyte-gliosis-like.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['POSTN', 'JPH1', 'EYA4', 'RTN1', 'LAMA2', 'AC092957.1', 'TNC', 'IGFBP7', 'COL23A1', 'NAMPT']\n",
      "\n",
      "**Response:**\n",
      "<think>\n",
      "We are given a list of genes that are enriched in malignant cells from a glioblastoma patient, and these cells are annotated as \"Astrocyte-gliosis-like\". Our task is to interpret what this gene list might say about the state, properties, and interactions of this cell type. We must consider normal cell biology, development, metabolic states, and interactions beyond just cancer literature.\n",
      "\n",
      "The genes are: ['POSTN', 'JPH1', 'EYA4', 'RTN1', 'LAMA2', 'AC092957.1', 'TNC', 'IGFBP7', 'COL23A1', 'NAMPT']\n",
      "\n",
      "We have search results from various sources that can help us understand the functions of these genes. We will go through each gene and relate it to astrocyte function, reactive astrogliosis, and the context of glioblastoma.\n",
      "\n",
      "1. **POSTN (Periostin)**: \n",
      "   - According to [7], POSTN is a matricellular protein that plays roles in survival, migration, and regeneration. It is expressed in the CNS during development and re-expressed after injury. It promotes neural stem cell (NSC) proliferation and differentiation. In the context of astrocytes, it might be involved in reactive astrogliosis and tissue remodeling. In glioblastoma, this could indicate a role in promoting tumor cell proliferation and invasion.\n",
      "\n",
      "2. **JPH1 (Junctophilin 1)**:\n",
      "   - From [12], junctophilins are involved in forming junctions between the endoplasmic reticulum (ER) and the plasma membrane, which are critical for calcium signaling. JPH1 is expressed in neural tissue and helps in stabilizing calcium microdomains. In astrocytes, calcium signaling is vital for their function. In the context of glioblastoma, dysregulation of calcium signaling might contribute to tumor cell survival and migration.\n",
      "\n",
      "3. **EYA4 (Eyes Absent Homolog 4)**:\n",
      "   - [14] indicates that EYA4 is a transcriptional coactivator involved in developmental processes, including in the nervous system. Mutations in EYA4 are associated with hearing loss, but its role in astrocytes is less clear. It might be involved in developmental pathways that are reactivated in cancer. In glioblastoma, it could contribute to aberrant transcriptional programs.\n",
      "\n",
      "4. **RTN1 (Reticulon 1)**:\n",
      "   - [2] and [13] discuss reticulons (RTNs) as ER-shaping proteins. RTN1-C interacts with MANF (mesencephalic astrocyte-derived neurotrophic factor), which is important for neuronal survival and ER stress responses [13]. In astrocytes, RTN1 might be involved in ER remodeling during stress. In glioblastoma, ER stress responses are often dysregulated, promoting survival under stress.\n",
      "\n",
      "5. **LAMA2 (Laminin Subunit Alpha 2)**:\n",
      "   - [18] describes LAMA2 as a component of laminins in the extracellular matrix (ECM), particularly in the basement membrane. It is crucial for blood-brain barrier (BBB) integrity and is produced by astrocytes. In glioblastoma, LAMA2 might contribute to the abnormal ECM that supports tumor invasion and angiogenesis.\n",
      "\n",
      "6. **AC092957.1**:\n",
      "   - This appears to be a long non-coding RNA (lncRNA). From [3] and [6], we see that AC092957.1 is mentioned in the context of genomic instability in low-grade gliomas (LGGs). LncRNAs can regulate gene expression epigenetically. In astrocytes, it might be involved in the regulation of reactive responses. In cancer, lncRNAs often contribute to oncogenic pathways.\n",
      "\n",
      "7. **TNC (Tenascin C)**:\n",
      "   - [11] and [17] highlight TNC as an ECM glycoprotein produced by reactive astrocytes. It is involved in development and injury responses, acting as a modulator of cell adhesion and migration. In glioblastoma, TNC is often upregulated and associated with poor prognosis, promoting invasion and resistance to therapy.\n",
      "\n",
      "8. **IGFBP7 (Insulin-like Growth Factor Binding Protein 7)**:\n",
      "   - [10] shows that IGFBP7 is downregulated in some cancers (like hepatocellular carcinoma) but may have context-dependent roles. It can act as a tumor suppressor by inducing senescence. In astrocytes, IGFBP7 might regulate responses to growth factors. In glioblastoma, it could be involved in autocrine/paracrine signaling.\n",
      "\n",
      "9. **COL23A1 (Collagen Type XXIII Alpha 1 Chain)**:\n",
      "   - [9] indicates that COL23A1 is a transmembrane collagen expressed by neurons in specific brain regions (like the accessory olfactory bulb). Its role in astrocytes is not well-established, but it might be involved in cell-matrix interactions. In cancer, collagens can influence tumor progression.\n",
      "\n",
      "10. **NAMPT (Nicotinamide Phosphoribosyltransferase)**:\n",
      "    - [15] and [16] discuss NAMPT as the rate-limiting enzyme in the NAD+ salvage pathway. Astrocytes use NAD+ for energy and immune responses. In [15], NAMPT is crucial for proinflammatory astrocyte activation. In glioblastoma, increased NAD+ metabolism might support tumor growth and resistance to stress.\n",
      "\n",
      "Now, integrating these genes into a cohesive picture of the \"Astrocyte-gliosis-like\" malignant cells:\n",
      "\n",
      "- **Reactive Astrocyte Signature**: The presence of TNC, POSTN, and LAMA2 suggests an extracellular matrix remodeling phenotype, typical of reactive astrocytes. This is further supported by COL23A1 (a collagen) and IGFBP7 (an ECM-associated protein). These genes indicate that the cells are producing an abnormal ECM that may facilitate invasion and angiogenesis.\n",
      "\n",
      "- **Calcium and ER Dynamics**: JPH1 and RTN1 point towards dysregulated calcium signaling and ER morphology. In reactive astrocytes, calcium waves are important for intercellular communication. In cancer, altered calcium signaling can promote proliferation and migration.\n",
      "\n",
      "- **Metabolic Reprogramming**: NAMPT is key in NAD+ metabolism. Reactive astrocytes often undergo metabolic shifts (e.g., towards glycolysis), and NAD+ is crucial for energy production and inflammation. In glioblastoma, this might support the high metabolic demands of tumor cells and modulate the tumor microenvironment.\n",
      "\n",
      "- **Developmental Pathways**: EYA4 is a transcriptional coactivator involved in development. Its re-expression in cancer might reactivate developmental programs that drive stem-like properties (e.g., in neural stem cells). This is consistent with the glioblastoma stem cell hypothesis.\n",
      "\n",
      "- **Non-coding RNA**: AC092957.1, as a lncRNA, might regulate these pathways epigenetically. LncRNAs can control chromatin states and gene expression, potentially maintaining the tumor-promoting state.\n",
      "\n",
      "- **Cross-cutting Metabolic States**: The NAD+ pathway (via NAMPT) links to cellular energetics and redox balance. Reactive astrocytes in glioblastoma might use NAD+ to fuel proinflammatory responses and resist oxidative stress.\n",
      "\n",
      "- **Cell-Cell Interactions**: \n",
      "  - Astrocytes normally interact with neurons, endothelial cells, and microglia. \n",
      "  - TNC and POSTN can modulate interactions with the ECM and other cells (e.g., immune cells). \n",
      "  - LAMA2 is critical for BBB integrity; its dysregulation might contribute to BBB breakdown in glioblastoma, facilitating immune cell infiltration and tumor spread.\n",
      "  - IGFBP7 might mediate interactions with growth factors (e.g., IGFs) in the microenvironment.\n",
      "\n",
      "- **Gliosis in Cancer**: Reactive astrogliosis is a response to injury, but in glioblastoma, this response is co-opted to support tumor growth. The gene list suggests a chronic, maladaptive gliosis that promotes tumor progression via ECM remodeling, altered metabolism, and dysregulated signaling.\n",
      "\n",
      "In conclusion, the gene signature indicates that the \"Astrocyte-gliosis-like\" malignant cells in glioblastoma exhibit:\n",
      "- A reactive ECM-remodeling phenotype (TNC, POSTN, LAMA2, COL23A1, IGFBP7)\n",
      "- Altered intracellular signaling (JPH1, RTN1, EYA4)\n",
      "- Metabolic adaptation with a focus on NAD+ metabolism (NAMPT)\n",
      "- Epigenetic regulation (AC092957.1)\n",
      "\n",
      "These properties likely contribute to tumor invasion, immune evasion, and resistance to therapy. The state resembles a chronic, non-resolving gliotic response that supports tumor growth.\n",
      "\n",
      "We will now structure the report accordingly.\n",
      "</think>\n",
      "### Enriched Gene Signature in Glioblastoma Astrocyte-Gliosis-Like Malignant Cells: Implications for Cellular State, Interactions, and Metabolic Reprogramming  \n",
      "\n",
      "The gene signature identified in malignant astrocyte-gliosis-like cells from glioblastoma patients—comprising **POSTN**, **JPH1**, **EYA4**, **RTN1**, **LAMA2**, **AC092957.1**, **TNC**, **IGFBP7**, **COL23A1**, and **NAMPT**—reveals a multifaceted cellular phenotype rooted in extracellular matrix (ECM) remodeling, metabolic dysregulation, and aberrant developmental signaling. This profile mirrors conserved astrocytic responses to injury, metabolic stress, and developmental pathways, now co-opted in malignancy. Below, we dissect the implications across cellular states, interactions, and metabolic adaptations, integrating insights from neurodevelopment, homeostasis, and disease contexts.  \n",
      "\n",
      "---\n",
      "\n",
      "### ECM Remodeling and Structural Dysregulation  \n",
      "Astrocyte-gliosis-like cells exhibit pronounced ECM dysregulation, driven by:  \n",
      "- **Tenascin-C (TNC)**: A key ECM glycoprotein re-expressed in reactive astrocytes under pathological conditions. TNC restricts astrogliosis and modulates astrocyte-microglial crosstalk, but in glioblastoma, its overexpression may facilitate invasive tumor growth by disrupting normal tissue architecture[11][17]. TNC's interaction with fibronectin domains and L-type Ca²⁺ channels further implicates it in calcium signaling dysregulation, a hallmark of glioma progression[11][17].  \n",
      "- **Periostin (POSTN)**: This matricellular protein promotes neural stem cell proliferation and differentiation. In glioblastoma, POSTN likely drives tumor expansion by enhancing cell adhesion, ECM deposition, and activation of integrin-mediated pathways[7]. Its homology to fasciclin I suggests roles in neurite outgrowth, potentially enabling network integration of malignant cells[7].  \n",
      "- **Laminin-α2 (LAMA2)**: Critical for blood-brain barrier (BBB) integrity, LAMA2 anchors astrocytes to endothelial cells via dystroglycan and α7β1 integrins. Loss of LAMA2 in neurovascular units correlates with BBB dysfunction, pericyte detachment, and reactive gliosis—features exacerbated in glioblastoma to promote angiogenesis and immune infiltration[18][8].  \n",
      "- **Collagen XXII Alpha 1 (COL23A1)**: A transmembrane collagen enriched in neuronal layers (e.g., mitral/tufted cells of the olfactory bulb). Its presence in glioblastoma implies aberrant re-activation of developmental collagen pathways, potentially altering cell-ECM signaling and tissue stiffness[9].  \n",
      "\n",
      "---\n",
      "\n",
      "### Intracellular Signaling and Organelle Dynamics  \n",
      "Dysregulation of endoplasmic reticulum (ER) and calcium homeostasis underpins malignant transformation:  \n",
      "- **Reticulon-1 (RTN1)**: Shapes ER tubules and modulates ER stress responses. RTN1-C interacts with mesencephalic astrocyte-derived neurotrophic factor (MANF), linking ER integrity to neuroprotection. In glioblastoma, RTN1 may drive adaptive ER expansion to support protein synthesis and stress survival[2][13].  \n",
      "- **Junctophilin-1 (JPH1)**: Tethers ER to the plasma membrane to regulate Ca²⁺ microdomains. JPH1 stabilizes Cav1-RyR2-KCa3.1 complexes in neurons; its dysregulation in astrocytes could disrupt Ca²⁺-dependent gliotransmission, promoting excitotoxicity and tumor invasion[12].  \n",
      "\n",
      "---\n",
      "\n",
      "### Metabolic Reprogramming  \n",
      "NAD⁺ salvage pathway activation fuels proinflammatory and survival pathways:  \n",
      "- **Nicotinamide Phosphoribosyltransferase (NAMPT)**: The rate-limiting enzyme in NAD⁺ biosynthesis. NAMPT upregulation in reactive astrocytes drives glycolysis and oxidative phosphorylation, supporting inflammatory gene transcription via CD38/NFAT signaling. In glioblastoma, this sustains tumor energy demands and evasion of oxidative stress[15][16].  \n",
      "- **Insulin-like Growth Factor Binding Protein 7 (IGFBP7)**: A senescence inducer downregulated in cancers. IGFBP7 binds activin A and heparan sulfate, modulating TGF-β signaling. Its loss in glioblastoma may disable tumor-suppressive ECM cues, while its re-expression could impair angiogenesis[10].  \n",
      "\n",
      "---\n",
      "\n",
      "### Developmental and Epigenetic Reawakening  \n",
      "Genes typifying neural development are aberrantly activated:  \n",
      "- **Eyes Absent Homolog 4 (EYA4)**: A transcriptional co-activator in sensory development. EYA4 mutations cause hearing loss via disrupted neurodevelopment. In glioblastoma, EYA4 may reactivate stemness programs, fostering dedifferentiation[14].  \n",
      "- **Long Non-Coding RNA AC092957.1**: Associated with genomic instability in gliomas. lncRNAs like AC092957.1 can silence tumor suppressors or amplify oncogenic pathways, contributing to the \"astrocyte-gliosis\" epigenetic landscape[3][6].  \n",
      "\n",
      "---\n",
      "\n",
      "### Cross-Tissue Interactions  \n",
      "Gliosis-like malignant cells engage in pathological crosstalk:  \n",
      "- **Neuron-Astrocyte Axis**: Calcium dysregulation (JPH1) and ECM disruption (TNC, POSTN) impair synaptic stability. TNC-mediated phagocytic pruning of synapses may be hijacked to eliminate neuronal inhibition of tumor growth[1][17].  \n",
      "- **Microglia and Immune Cells**: TNC and IGFBP7 modulate cytokine release (e.g., via NF-κB), recruiting microglia. NAD⁺-driven astrocyte inflammation (NAMPT) further polarizes immune cells toward tumor tolerance[11][15][17].  \n",
      "- **Vascular Niche**: LAMA2 loss and TNC overexpression degrade BBB tight junctions, facilitating angiogenesis. Hypoxia-inducible factors (e.g., HIF-1α) may synergize with NAMPT to fuel metabolic adaptation in perivascular niches[8][15][18].  \n",
      "\n",
      "---\n",
      "\n",
      "### Metabolic State Integration  \n",
      "Astrocyte-gliosis-like cells exhibit a \"Warburg-like\" metabolic shift:  \n",
      "1. **Glycolytic Flux**: NAMPT-driven NAD⁺ recycling enhances glycolysis, supplying ATP for phagocytic and inflammatory activity—mirroring reactive astrocytes in neurodegeneration[1][15].  \n",
      "2. **Lipid and Protein Stress**: RTN1 and JPH1 alter ER morphology, disrupting lipid metabolism and protein folding. This may activate unfolded protein responses, increasing chaperone expression (e.g., HSP90)[4][12].  \n",
      "3. **Redox Imbalance**: NAD⁺ depletion amplifies oxidative stress. Paradoxically, NAMPT upregulation may counter this by fueling antioxidant pathways, illustrating a metabolic trade-off in malignancy[16].  \n",
      "\n",
      "---\n",
      "\n",
      "### Conclusion  \n",
      "The enriched gene signature in astrocyte-gliosis-like glioblastoma cells depicts a maladaptive state where developmental, metabolic, and structural programs converge. Key features include:  \n",
      "- **ECM Dysplasia**: TNC, POSTN, and LAMA2 create a tumor-permissive matrix.  \n",
      "- **Metabolic Plasticity**: NAMPT sustains inflammation and stress resilience.  \n",
      "- **Developmental Reversion**: EYA4 and AC092957.1 reawaken neural stem cell-like traits.  \n",
      "- **Network Dysfunction**: Altered ER/calcium dynamics (RTN1, JPH1) and immune crosstalk drive progression.  \n",
      "\n",
      "This phenotype mirrors conserved astrocyte responses to injury but is locked in a self-amplifying loop of invasion and metabolic opportunism. Targeting NAMPT or TNC may disrupt this equilibrium, offering therapeutic entry points[11][15][17]. Future work should explore single-cell spatial transcriptomics to deconvolute heterogeneous glioblastoma microenvironments.\n",
      "\n",
      "\n",
      "\n",
      "## References\n",
      "\n",
      "- [1] https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2024.1393253/full\n",
      "- [2] https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2020.00048/full\n",
      "- [3] https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.758596/text\n",
      "- [4] https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2023.1173200/pdf\n",
      "- [5] https://journals.plos.org/plosone/article/file?type=supplementary&id=10.1371%2Fjournal.pone.0032917.s003\n",
      "- [6] https://www.frontiersin.org/api/v4/articles/937531/file/Table_2.xlsx/937531_supplementary-materials_tables_2_xlsx/2\n",
      "- [7] https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0123585\n",
      "- [8] https://pubmed.ncbi.nlm.nih.gov/36098369/\n",
      "- [9] https://www.frontiersin.org/journals/integrative-neuroscience/articles/10.3389/fnint.2017.00020/full\n",
      "- [10] https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.00727/full\n",
      "- [11] https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2012.00120/full\n",
      "- [12] https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2021.635518/full\n",
      "- [13] https://pubmed.ncbi.nlm.nih.gov/25543119/\n",
      "- [14] https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126602\n",
      "- [15] https://pubmed.ncbi.nlm.nih.gov/35994674/\n",
      "- [16] https://pubmed.ncbi.nlm.nih.gov/27002158/\n",
      "- [17] https://pubmed.ncbi.nlm.nih.gov/35430380/\n",
      "- [18] https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2020.00118/full\n",
      "- [19] https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.607587/full\n",
      "------------------------------------------\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# testing a single report first to see the output\n",
    "print(\"--- Generating a single report preview ---\")\n",
    "single_report = generate_report(results[0])\n",
    "print(single_report)\n",
    "print(\"------------------------------------------\\n\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "ba57d3d2-bee5-4175-8b7b-61995b570de4",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Saving separate reports to: ./output/deepsearch_caroline/\n",
      "All separate reports have been saved successfully.\n"
     ]
    }
   ],
   "source": [
    "output_directory = './output/deepsearch_caroline/'\n",
    "\n",
    "# Call the function to generate and save all reports to the new directory\n",
    "generate_and_save_all_reports(results, output_directory)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "b187371e-efa6-4b32-90a4-25f04a412a70",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python (omer-env)",
   "language": "python",
   "name": "omer-env"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.13.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
